Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists
Clinical trial NCT07221461 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07221461
- Sponsor
- Goldman, Butterwick, Fitzpatrick and Groff
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2026-01-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.